News Picture Generic

Development of a High-Throughput Kinetics Protocol and Application to an Aza-Michael Reaction

October 29, 2024

Organic Process Research & Development

High-throughput experimentation (HTE) has become integral to the pharmaceutical industry with most major pharmaceutical companies investing in automation and high-throughput screening technologies. Testing hundreds of reactions in parallel has distinct advantages; however, one clear disadvantage is that performing a reaction on micromolar scale is not always indicative of the reaction’s performance on multikilogram scale. Additionally, a great deal of information is lost by looking at a single time point. Valuable data around intermediates, over-reaction, catalyst induction periods, and so forth are invisible to a typical HTE workflow, which involves analyzing reactions at a single time point (e.g., 18 h). We envisioned a workflow in which time courses for each well of a high-throughput screen were collected. With this change in strategy, it could then become possible to complete high-throughput screening, select reaction conditions, gather kinetic information, and successfully build a kinetic model in less than 1 week. A kinetic model consisting of scale-independent parameters allows for virtual reaction optimization where the input concentrations, catalyst loading, and temperature can all be simulated and adjusted to understand their impact on yield or quality in a matter of seconds. A case study is presented with a transition metal salt/TMSCl-catalyzed aza-Michael reaction to showcase the performance and robustness of the high-throughput kinetic platform. A reaction progress kinetic analysis approach is utilized to quickly screen the rates of 48 catalyst/solvent combinations and create a mechanistic model. The first-principles kinetic model provides support for a proposed mechanism of dual activation by TMSCl.

For details

Development of a High-Throughput Kinetics Protocol and Application to an Aza-Michael Reaction

Xiao Li 1/2 and Anna L. Dunn 1

  1. Pharmaceutical Development, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States
  2. William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas 77004, United States

DOI: https://pubs.acs.org/doi/10.1021/acs.oprd.1c00213

For more information about the used Chemspeed solutions:

FLEX ISYNTH with online NMR

ISYNTH REACTSCREEN 

AUTOPLANT PRORES

Contact us to learn more about this exciting publication:

https://www.chemspeed.com/contact-us/

Other Recent News

Discover more news articles you might be interested in

Read more about An Automation Platform for the Chemoenzymatic Synthesis of Complex Sulfated and Branched Glycans
News Picture 1 1 V2
Apr
28

An Automation Platform for the Chemoenzymatic Synthesis of Complex Sulfated and Branched Glycans

Diverse collections of well-defined glycans are needed to investigate the molecular mechanisms by which these biomolecules mediate biological and disease processes. Several automation approaches have been introduced to accelerate the enzymatic synthesis of complex glycans. These methodologies have, however, provided only relatively simple oligosaccharides due to limitations of glycosyl transferase selectivity.

Read more about Accelerating Porosity Assessment in Solid Materials via SemiAutomated Platforms
News Picture 1 1 V2
Featured
Apr
21

Accelerating Porosity Assessment in Solid Materials via SemiAutomated Platforms

The design and discovery of porous materials have become a central theme in materials science, driven by their applications in gas storage, separation, carbon capture, and catalysis. Rapid advances in synthetic chemistry, particularly in metal–organic frameworks, porous organic cages, and conjugated microporous polymers, have enabled the generation of increasingly large and diverse material libraries.

Read more about Implementation of Large-Scale Multi-Reactor Automation for Process Development
News Picture 1 1 V2
Apr
14

Implementation of Large-Scale Multi-Reactor Automation for Process Development

Pharmaceuticals increasing complexity requires longer synthesis with unique processes for each step, increasing the number of experiments to develop robust sustainable processes. The time to develop these processes is getting shorter, and automation can support the growing need to efficiently perform more experiments.

© Chemspeed Technologies 2026